Published in Am J Respir Crit Care Med on April 01, 2001
Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care | NCT00440687
Prospective evAluatIon foR Inhalation Devices Study (P A I R) | NCT01800994
Searching Chronic Obstructive Pulmonary Disease Onset (SOON) | NCT03026439
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax (2004) 8.09
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J (2013) 4.65
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56
Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 4.15
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax (2006) 4.04
Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax (2003) 3.90
Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax (2003) 3.62
Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet (2007) 3.22
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med (2004) 3.12
The new contract: renaissance or requiem for general practice? Br J Gen Pract (2002) 3.01
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Smokers with airway obstruction are more likely to quit smoking. Thorax (2006) 2.91
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax (2013) 2.88
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med (2010) 2.85
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med (2008) 2.79
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation (2009) 2.70
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Statin use reduces decline in lung function: VA Normative Aging Study. Am J Respir Crit Care Med (2007) 2.65
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med (2005) 2.61
State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc (2006) 2.60
Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax (2006) 2.55
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail (2009) 2.51
SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 2.49
Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax (2010) 2.43
Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.42
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42
Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir Res (2006) 2.40
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ (2003) 2.40
Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax (2004) 2.40
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. BMJ (2002) 2.35
The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: a cross-sectional study. Ann Intern Med (2010) 2.34
Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax (2003) 2.33
Long-term air pollution exposure and living close to busy roads are associated with COPD in women. Respir Res (2005) 2.32
Mechanistic links between COPD and lung cancer. Nat Rev Cancer (2013) 2.28
Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med (2007) 2.24
Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax (2006) 2.21
Occupational exposures and the risk of COPD: dusty trades revisited. Thorax (2008) 2.20
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med (2004) 2.19
Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev (2007) 2.14
The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell-dependent emphysema. Nat Immunol (2015) 2.13
Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. Thorax (2013) 2.13
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 2.06
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res (2006) 2.03
Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax (2005) 1.99
Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. Respir Res (2008) 1.98
Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax (2006) 1.96
Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis (2014) 1.95
Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax (2005) 1.92
Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax (2007) 1.92
COPD exacerbations . 2: aetiology. Thorax (2006) 1.90
Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax (2004) 1.89
Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A (2007) 1.89
Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med (2006) 1.88
Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease. Thorax (2004) 1.85
Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med (2013) 1.82
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax (2005) 1.81
Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol (2001) 1.78
Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax (2005) 1.76
Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med (2006) 1.76
Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76
Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2012) 1.72
Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One (2009) 1.71
Wheeze, asthma diagnosis and medication use: a national adult survey in a developing country. Thorax (2005) 1.71
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax (2003) 1.70
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2010) 1.69
Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol (2006) 1.69
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res (2005) 1.68
Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials. BMJ (2003) 1.68
Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD (2011) 1.66
Cigarette smoke induces cellular senescence. Am J Respir Cell Mol Biol (2006) 1.66
Effects of singing classes on pulmonary function and quality of life of COPD patients. Int J Chron Obstruct Pulmon Dis (2009) 1.66
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med (2011) 1.65
Airway wall thickness assessed using computed tomography and optical coherence tomography. Am J Respir Crit Care Med (2008) 1.64
Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008. COPD (2013) 1.64
Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. AJR Am J Roentgenol (2013) 1.63
Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med (2007) 1.63
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax (2006) 1.60
Relation between duration of smoking cessation and bronchial inflammation in COPD. Thorax (2005) 1.60
Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax (2002) 1.59
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax (2005) 1.58
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma. Thorax (2004) 1.58
Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax (2005) 1.58
Lung function decline and outcomes in an elderly population. Thorax (2006) 1.57
COPD as a systemic disease: impact on physical functional limitations. Am J Med (2008) 1.57
Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J Allergy Clin Immunol (2008) 1.56
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54
Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance. Hypertension (2013) 1.54
Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health (2009) 1.54
Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women. Am J Clin Nutr (2008) 1.54
Chronic cor pulmonale. Heart (2003) 1.53
Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res (2005) 1.53
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet (1979) 4.85
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65
Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics (1987) 4.10
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003. COPD (2004) 3.14
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet (1999) 2.90
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J (2003) 2.57
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.52
Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax (2000) 2.41
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28
Accuracy sensitivity to carboxyhemoglobin, and speed of response of the Hewlett-Packard 47201A ear oximeter. Am Rev Respir Dis (1979) 2.17
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med (1994) 2.11
Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06
Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99
Increasing COPD awareness. Eur Respir J (2006) 1.94
Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax (1997) 1.80
Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med (2001) 1.79
Comparison of ipratropium bromide and salbutamol by aerosolized solution. Aust N Z J Med (1981) 1.77
Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med (1987) 1.74
Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Chest (1994) 1.71
Preventing deaths from asthma. N Engl J Med (1994) 1.70
Irregular breathing and hypoxaemia during sleep in chronic stable asthma. Lancet (1982) 1.65
Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med (2001) 1.65
Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis (1988) 1.63
The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis (1982) 1.62
Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? Int J Tuberc Lung Dis (2009) 1.60
Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis (1983) 1.58
Paradoxical movement of the lower ribcage at rest and during exercise in COPD patients. Eur Respir J (2008) 1.57
Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis (1973) 1.56
Restricted spirometry in the Burden of Lung Disease Study. Int J Tuberc Lung Dis (2012) 1.55
Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med (1999) 1.54
Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med (1998) 1.53
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax (1990) 1.53
Relative impact of smoking and reduced pulmonary function on peptic ulcer risk. A prospective study of Japanese men in Hawaii. Gastroenterology (1989) 1.52
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J (2001) 1.50
Monitoring recruitment effectiveness and cost in a clinical trial. Control Clin Trials (1993) 1.49
An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Respir Med (1999) 1.46
Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J (1992) 1.45
Heroin inhalation and asthma. BMJ (1988) 1.45
When can personal best peak flow be determined for asthma action plans? Thorax (2004) 1.45
Double blind randomised controlled trial of two different breathing techniques in the management of asthma. Thorax (2006) 1.45
Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax (1995) 1.42
Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease. Chest (1999) 1.42
Smoking cessation: professional problem or public policy? Respir Med (1996) 1.42
COPD exacerbations: the importance of a standard definition. Respir Med (2004) 1.42
Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med (1994) 1.42
Recruiting hard-to-reach subjects: is it worth the effort? Control Clin Trials (1994) 1.41
Cigarette smoking and secondary polycythemia in hypoxic cor pulmonale. Am Rev Respir Dis (1982) 1.41
Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med (1995) 1.40
20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med (1998) 1.40
The pulmonary academic "transitional track". How do we get them out of the nest? Am Rev Respir Dis (1989) 1.39
Caesarean section delivery and the risk of allergic disorders in childhood. Clin Exp Allergy (2005) 1.36
Probable formation of partially phosphorylated intermediates in the interconversions of phosphorylase A and B. Biochem Biophys Res Commun (1966) 1.35
Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J (2000) 1.34
Pitfalls in processing home electronic spirometric data in asthma. Eur Respir J (1998) 1.30
A comparison of conventional spirometric tests and the test of closing volume in an emphysema screening center. Am Rev Respir Dis (1973) 1.30
Prospective study of pulmonary function and lung cancer. Am Rev Respir Dis (1991) 1.29
The effect of smoking cessation and modification on lung function. Am Rev Respir Dis (1976) 1.26
Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med (2001) 1.24
Acute bronchodilator trials in chronic obstructive pulmonary disease. Am Rev Respir Dis (1992) 1.23
Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy (1988) 1.22
Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA (1993) 1.21
Wood smoke exposure, poverty and impaired lung function in Malawian adults. Int J Tuberc Lung Dis (2011) 1.20
Acute effects of volcanic ash from Mount Saint Helens on lung function in children. Am Rev Respir Dis (1983) 1.15
The effect of smoking cessation on pulmonary function: a 30-month follow-up of two smoking cessation clinics. Am Rev Respir Dis (1979) 1.13
Anti-smoking advice for young diabetic smokers: is it a waste of breath? Diabet Med (1988) 1.12
Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol (1995) 1.11
Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Thorax (2001) 1.09
Gastropleural fistula due to gastric lymphoma presenting as tension pneumothorax and empyema. Eur Respir J (1997) 1.09
Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax (1985) 1.08
Preventive health measures in volcanic eruptions. Am J Public Health (1986) 1.08